Sebia Receives U.S. FDA Clearance for the FLC Kappa & Lambda Assays

Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S....

Related Keywords

Ulisses ,France General ,France ,Quebec ,Canada ,Arnaud Collin ,Drug Administration ,Sebia Group Vice ,Global Regulatory Affairs Quality ,Product Service ,International Myeloma Working Group ,Multiple Myeloma ,Immunoglobulin Light Chain ,Zeus Scientific ,Tethys Invest ,Myeloma Working Group ,